958 related articles for article (PubMed ID: 24433988)
1. [Misoprostol: off-label use in the first trimester of pregnancy (spontaneous abortion, and voluntary medical termination of pregnancy)].
Beucher G; Dolley P; Carles G; Salaun F; Asselin I; Dreyfus M
J Gynecol Obstet Biol Reprod (Paris); 2014 Feb; 43(2):123-45. PubMed ID: 24433988
[TBL] [Abstract][Full Text] [Related]
2. Overview and expert assessment of off-label use of misoprostol in obstetrics and gynaecology: review and report by the Collège national des gynécologues obstétriciens français.
Marret H; Simon E; Beucher G; Dreyfus M; Gaudineau A; Vayssière C; Lesavre M; Pluchon M; Winer N; Fernandez H; Aubert J; Bejan-Angoulvant T; Jonville-Bera AP; Clouqueur E; Houfflin-Debarge V; Garrigue A; Pierre F;
Eur J Obstet Gynecol Reprod Biol; 2015 Apr; 187():80-4. PubMed ID: 25701235
[TBL] [Abstract][Full Text] [Related]
3. [Misoprostol in case of termination of pregnancy in the second and third trimesters. Trials].
Pluchon M; Winer N
J Gynecol Obstet Biol Reprod (Paris); 2014 Feb; 43(2):162-8. PubMed ID: 24440001
[TBL] [Abstract][Full Text] [Related]
4. [Obtaining of uterine vacuity in pregnancy loss].
Beucher G; Dolley P; Stewart Z; Lavoué V; Deffieux X; Dreyfus M
J Gynecol Obstet Biol Reprod (Paris); 2014 Dec; 43(10):794-811. PubMed ID: 25447362
[TBL] [Abstract][Full Text] [Related]
5. [Use of misoprostol for induction of labor in case of fetal death or termination of pregnancy during second or third trimester of pregnancy: Efficiency, dosage, route of administration, side effects, use in case of uterine scar].
Clouqueur E; Coulon C; Vaast P; Chauvet A; Deruelle P; Subtil D; Houfflin-Debarge V
J Gynecol Obstet Biol Reprod (Paris); 2014 Feb; 43(2):146-61. PubMed ID: 24461423
[TBL] [Abstract][Full Text] [Related]
6. [First trimester miscarriages: benefits and harms of different management options].
Beucher G; Dolley P; Stewart Z; Carles G; Dreyfus M
Gynecol Obstet Fertil; 2014 Sep; 42(9):608-21. PubMed ID: 25153436
[TBL] [Abstract][Full Text] [Related]
7. Cervical preparation for first trimester surgical abortion.
Kapp N; Lohr PA; Ngo TD; Hayes JL
Cochrane Database Syst Rev; 2010 Feb; (2):CD007207. PubMed ID: 20166091
[TBL] [Abstract][Full Text] [Related]
8. Use of mifepristone and sublingual misoprostol for early medical abortion.
Lin M; Li YT; Chen FM; Wu SF; Tsai CW; Chen TH; Kuo TC
Taiwan J Obstet Gynecol; 2006 Dec; 45(4):321-4. PubMed ID: 17175490
[TBL] [Abstract][Full Text] [Related]
9. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation.
Hamoda H; Ashok PW; Flett GM; Templeton A
BJOG; 2005 Aug; 112(8):1102-8. PubMed ID: 16045525
[TBL] [Abstract][Full Text] [Related]
10. [Medical induced abortion].
Bettahar K; Pinton A; Boisramé T; Cavillon V; Wylomanski S; Nisand I; Hassoun D
J Gynecol Obstet Biol Reprod (Paris); 2016 Dec; 45(10):1490-1514. PubMed ID: 27818118
[TBL] [Abstract][Full Text] [Related]
11. Vaginal vs. sublingual misoprostol with mifepristone for cervical priming in second-trimester abortion by dilation and evacuation: a randomized clinical trial.
Carbonell JL; Gallego FG; Llorente MP; Bermudez SB; Sala ES; González LV; Texido CS
Contraception; 2007 Mar; 75(3):230-7. PubMed ID: 17303495
[TBL] [Abstract][Full Text] [Related]
12. A randomized study comparing the use of sublingual to vaginal misoprostol for pre-operative cervical priming prior to surgical termination of pregnancy in the first trimester.
Tang OS; Mok KH; Ho PC
Hum Reprod; 2004 May; 19(5):1101-4. PubMed ID: 15070888
[TBL] [Abstract][Full Text] [Related]
13. Sublingual versus vaginal misoprostol for cervical ripening PRIOR TO manual vacuum aspiration under local anaesthesia: a randomized study.
Caliskan E; Filiz T; Yucesoy G; Coskun E; Vural B; Corakci A
Eur J Contracept Reprod Health Care; 2007 Dec; 12(4):372-7. PubMed ID: 17853158
[TBL] [Abstract][Full Text] [Related]
14. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
Guest J; Chien PF; Thomson MA; Kosseim ML
BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893
[TBL] [Abstract][Full Text] [Related]
15. A randomised comparison between sublingual, oral and vaginal route of misoprostol for pre-abortion cervical ripening in first-trimester pregnancy termination under local anaesthesia.
Saxena P; Sarda N; Salhan S; Nandan D
Aust N Z J Obstet Gynaecol; 2008 Feb; 48(1):101-6. PubMed ID: 18275580
[TBL] [Abstract][Full Text] [Related]
16. Buccal misoprostol for cervical ripening prior to first trimester abortion.
Panchal HB; Godfrey EM; Patel A
Contraception; 2010 Feb; 81(2):161-4. PubMed ID: 20103456
[TBL] [Abstract][Full Text] [Related]
17. A randomized trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion at 13-20 weeks gestation.
Hamoda H; Ashok PW; Flett GM; Templeton A
Hum Reprod; 2005 Aug; 20(8):2348-54. PubMed ID: 15878927
[TBL] [Abstract][Full Text] [Related]
18. The management of missed miscarriage in an outpatient setting: 800 versus 600 μg of vaginal misoprostol.
Barceló F; De Paco C; López-Espín JJ; Silva Y; Abad L; Parrilla JJ
Aust N Z J Obstet Gynaecol; 2012 Feb; 52(1):39-43. PubMed ID: 22145604
[TBL] [Abstract][Full Text] [Related]
19. [Assessment of efficacy and safety of medical treatment of non-viable first trimester pregnancy].
Zwierzchowska A; Głuszak M; Jabiry-Zieniewicz Z; Banaszek-Wysoczańska A; Dziadecki W; Barcz E
Ginekol Pol; 2012 Oct; 83(10):760-5. PubMed ID: 23383562
[TBL] [Abstract][Full Text] [Related]
20. A randomized controlled comparison of sublingual and vaginal administration of misoprostol for cervical priming before first-trimester surgical abortion.
Hamoda H; Ashok PW; Flett GM; Templeton A
Am J Obstet Gynecol; 2004 Jan; 190(1):55-9. PubMed ID: 14749635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
